Cinven Completes Amdipharm Acquisition

European private equity firm, Cinven has completed the acquisition of Amdipharm, a family-owned international niche pharmaceuticals business, for a total consideration of 367 million pounds ($593.3 million). This follows Cinven’s acquisition of Mercury Pharma, an international specialty pharmaceuticals company, in August 2012.

DealsNorth AmericaUSBriefs